Cloud Hosting

The massive price correction in May caused many crypto investors to lose most of the gains they amassed earlier in the year. However, such price corrections are necessary to weed out the unnecessary crypto projects, bolster the tangible ones, and provide a better proving ground for hopeful and aspiring cryptocurrencies. Enzyme (MLN) has emerged as one of those altcoins. The crypto has made a name for itself during the latest lull.

While most of the market has been slow to gain ground due to the losses they experienced in May, crypto investors are looking to get back their profits as soon as possible. Looking for the next substantial cryptocurrency to invest in early has proven to be more difficult lately. However, looking at hype and momentum surrounding certain altcoins can help investors narrow in on a quick win.

Enzyme has benefited from such activity. Thanks to trading activity, strategic partnerships, and being added to exchanges, Enzyme has stood out from the crowd. But is it a good buy?

Many factors can help a digital token gain value and lose value. Timing when a cryptocurrency will increase is pure speculation. By the time news is out about a particular token, its likely already hit its peak and on its way back down.

Article continues below advertisement

But with Enzyme, the momentum has been pretty consistent. After the big drop in May, Enzyme quickly rebounded to record heights. It has since come back down but has hovered around pre-crash levels.

Article continues below advertisement

Enzyme saw a surge in its price amid the announcement that the MLN token would start trading on Binance on July 5. Being added to the largest crypto exchange in the world helped MLN spike 55 percent in the price to a high of $125. In the 24 hours after listing on Binance, the trading volume for MLN also surged by more than 2,000 percent to $148 million.

On July 5, Enzyme announced a collaboration with Yearn.finance. Through the partnership, Yearns vaults will now be available on the Enzyme protocol. This allows portfolio managers on Enzyme to use yield farming strategies through Yearn as part of their overall investment strategy.

Article continues below advertisement

Yearn.finance has become one of the most expansive and cross-integrated DeFi platforms, and the Enzyme integration further entrenches them among the top.

View original post here:
Should You Buy Enzyme Crypto as the Altcoin Rallies? - Market Realist